The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment

J. Baker, A. Banerjee (Southampton, United Kingdom)

Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Session: Diagnosis, imaging and surgery for thoracic tumours
Session type: Thematic Poster Session
Number: 2773
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Baker, A. Banerjee (Southampton, United Kingdom). The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment. Eur Respir J 2014; 44: Suppl. 58, 2773

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007



Impact of PET scan on staging and management of lung cancer patients in Indian scenario
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer
Source: Annual Congress 2005 - Management of lung cancer: clinical problems
Year: 2005


Non small cell lung cancer (NSCLC): 42 patients treated with computed tomography (CT) guided percutaneous microwave ablation
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015


False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014


Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET)
Source: Eur Respir J 2004; 24: Suppl. 48, 457s
Year: 2004

Algorithm of preoperative N-staging of non-small cell lung cancer
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013


Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Surgery for nonsmall cell lung cancer: can improvements be made?
Source: Eur Respir J 2003; 21: 52S-56S
Year: 2003



The visibility of virtual-assisted lung mapping (VAL-MAP) on computed tomography for thoracoscopic lung tumor resection
Source: International Congress 2016 – Current challenges in thoracic surgery
Year: 2016


Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016


The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010